Colombier Acquisition Corp. II (CLBR) is a special purpose acquisition company (SPAC) focused on identifying and merging with high-growth businesses primarily within the technology and healthcare sectors. With a seasoned management team and a wide-ranging strategic network, CLBR aims to leverage its expertise to unlock transformative investment opportunities that capitalize on market trends. The firm's commitment to providing significant shareholder value through strategic acquisitions positions it as an attractive option for institutional investors seeking exposure to innovative companies poised for scalable growth in a dynamic economic environment.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.87% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.36 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 229.10% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.25M |
| Float | $11.84M |
| % Insiders | 0.00% |
| % Institutions | 85.59% |
Volatility is currently expanding
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLBR and any ticker you trade — then tracks every position and per-strategy win rate.